|
1）Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995; 40: 1561-8. Epub 1995/07/01
|
|
|
|
2）Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. New Engl J Med. 2001; 344: 732-8
|
|
|
|
|
|
3）Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002; 359: 1403-4. Epub 2002/04/30
|
|
|
|
|
|
4）Kawa S, Hamano H, Kiyosawa K. Autoimmune pancreatitis and IgG4-related disease. In: Rose N, editors. The autoimmune diseases. 5th ed. St Louis: Academic Press; 2013. p.935-49
|
|
|
|
|
|
5）Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011; 40: 352-8. Epub 2011/03/18
|
|
|
|
|
|
6）Maruyama M, Watanabe T, Kanai K, et al. Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis. 2014; 9: 77
|
|
|
|
|
|
7）Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013; 108: 610-7. Epub 2013/01/16
|
|
|
|
|
|
8）Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol. 2004; 99: 932-7. Epub 2004/05/07
|
|
|
|
|
|
9）Kawa S, Hamano H, Ozaki Y, et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol. 2009; 7(11 Suppl): S18-22. Epub 2009/12/05
|
|
|
|
|
|
10）Maruyama M, Arakura N, Ozaki Y, et al. Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course. J Gastroenterol. 2012; 47: 553-60. Epub 2011/12/21
|
|
|
|
|
11）Maruyama M, Arakura N, Ozaki Y, et al. Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term followed-up study of 73 Japanese patients. Int J Rheumatol. 2013; 2013: 272595
|
|
|
|
|
|
12）丸山真弘，新倉則和，尾崎弥生，他．自己免疫性膵炎は慢性膵炎に移行しうる．肝胆膵．2013; 67: 399-407
|
|
|
|
|
|
13）丸山真弘，新倉則和，尾崎弥生，他．自己免疫性膵炎と膵石症．胆と膵．2013; 34: 737-44
|
|
|
|
|
|
14）丸山真弘，渡邉貴之，金井圭太，他．自己免疫性膵炎の進展と改善．肝胆膵．2014; 68: 695-703
|
|
|
|
|
|
15）Suzuki K, Itoh S, Nagasaka T, et al. CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT. Clin Radiol. 2010; 65: 735-43. Epub 2010/08/11
|
|
|
|
|
|
16）Sah RP, Pannala R, Chari ST, et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol. 2010; 8: 91-6. Epub 2009/10/06
|
|
|
|
|
|
17）Takuma K, Kamisawa T, Tabata T, et al. Short-term and long-term outcomes of autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2011; 23: 146-52. Epub 2011/02/03
|
|
|
|
|
|
18）Zhang X, Zhang X, Li W, et al. Clinical analysis of 36 cases of autoimmune pancreatitis in China. PLoS One. 2012; 7: e44808. Epub 2012/10/03
|
|
|
|
|
|
19）Hirano K, Tada M, Isayama H, et al. High alcohol consumption increases the risk of pancreatic stone formation and pancreatic atrophy in autoimmune pancreatitis. Pancreas. 2013; 42: 502-5. Epub 2012/11/14
|
|
|
|
|
|
20）五十嵐久人，大野隆真，伊藤鉄英，他．自己免疫性膵炎の長期的変化 自己免疫性膵炎における膵石の発生．肝胆膵．2010; 60: 79-86
|
|
|
|
|
|
21）Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013; 62: 1771-6. Epub 2012/12/11
|
|
|
|
|
|
22）Maire F, Le Baleur Y, Rebours V, et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol. 2011; 106: 151-6. Epub 2010/08/26
|
|
|
|
|
|
23）Miyamoto Y, Kamisawa T, Tabata T, et al. Short and long-term outcomes of diabetes mellitus in patients with autoimmune pancreatitis after steroid therapy. Gut Liver. 2012; 6: 501-4. Epub 2012/ 11/22
|
|
|
|
|
|
24）Hirano K, Isogawa A, Tada M, et al. Long-term prognosis of autoimmune pancreatitis in terms of glucose tolerance. Pancreas. 2012; 41: 691-5. Epub 2012/01/18
|
|
|
|
|
|
25）Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all ‘chronic pancreatitis’? Am J Surg Pathol. 2003; 27: 110-20. Epub 2002/12/28
|
|
|
|
|
|
26）Schnelldorfer T, Lewin DN, Adams DB. Long-term results after surgery for autoimmune sclerosing pancreatitis. J Gastrointest Surg. 2007; 11: 56-8. Epub 2007/03/29
|
|
|
|
|
|
27）Clark CJ, Morales-Oyarvide V, Zaydfudim V, et al. Short-term and long-term outcomes for patients with autoimmune pancreatitis after pancreatectomy: a multi-institutional study. J Gastrointest Surg. 2013; 17: 899-906. Epub 2013/01/16
|
|
|
|
|
|
28）Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012; 22: 414-8. Epub 2011/09/07
|
|
|
|
|
|
29）Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014; 53: 171-6. Epub 2014/02/05
|
|
|
|
|
|
30）Hart PA, Law RJ, Dierkhising RA, et al. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014; 43: 417-21. Epub 2014/03/14
|
|
|
|
|
|
31）Matsubayashi H, Matsunaga K, Uesaka K, et al. A case of pancreatic carcinoma with suspected autoimmune pancreatitis. Clin J Gastroenterol. 2009; 2: 59-63
|
|
|
|
|
|
32）Motosugi U, Ichikawa T, Yamaguchi H, et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int. 2009; 59: 744-7. Epub 2009/10/01
|
|
|
|
|
|
33）Gupta R, Khosroshahi A, Shinagare S, et al. Does autoimmune pancreatitis increase the risk of pancreatic carcinoma?: a retrospective analysis of pancreatic resections. Pancreas. 2013; 42: 506-10. Epub 2012/12/29
|
|
|
|
|
|
34）宮谷博幸，澤田幸久，井上博睦，他．自己免疫性膵炎の長期的変化 自己免疫性膵炎における膵癌の発生．肝胆膵．2010; 60: 87-92
|
|
|
|
|
|
35）田中滋城，吉田 仁，池上覚俊，他．自己免疫性膵炎の治療と予後．膵臓．2007; 22: 663-7
|
|
|
|
|
|
36）岡崎和一，川 茂幸，神澤輝実，他．自己免疫性膵炎診療ガイドライン2013．膵臓．2013; 28: 715-83
|
|
|
|
|
|
37）Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007; 56: 1719-24. Epub 2007/05/26
|
|
|
|
|
|
38）Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc. 2007; 66: 1142-51. Epub 2007/12/07
|
|
|
|
|
|
39）Kamisawa T, Tsuruta K, Okamoto A, et al. Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas. 2009; 38: 890-5. Epub 2009/09/16
|
|
|
|
|